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Natural history of carotid artery occlusion
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Ali F. AbuRahma, MD, Patrick A. Stone, MD, Shadi Abu-Halimah, MD, and Christine A. Welch, MS,
Charleston, WV
Background: The natural history of patients with carotid artery occlusion is controversial. A few studies have concluded
that patients with internal carotid artery occlusion carry a high risk of neurologic events. None of these previously
reported studies analyze the natural history of internal artery occlusion contralateral to carotid endarterectomy (CEA),
except for a small series including a subset of patients from two randomized trials, the Asymptomatic Carotid
Atherosclerosis Study and the North American Symptomatic Carotid Endarterectomy Trial. This study analyzes the
natural history of patients with carotid artery occlusion contralateral to CEA, specifically assessing long-term neurologic
events occurring in the hemisphere associated with the occluded carotid artery.
Methods: Of the 599 CEAs in 544 patients that were included in two previously updated prospective studies, 63 patients
had contralateral internal carotid artery occlusion, and their perioperative and long-term outcomes were evaluated. A
Kaplan-Meier analysis was used to estimate the rate of freedom from late stroke occurring in the hemisphere ipsilateral to
the occluded carotid artery. The stroke-free survival rate was also noted.
Results:Mean follow-up was 58 months (range, 1 to 147 months). One perioperative stroke (1.6%) occurred, which was
not in the cerebral hemisphere ipsilateral to the occluded carotid artery. Two late strokes (3.2%) and nine transient
ischemic attacks (TIAs) (14.3%) occurred involving the hemisphere of the occluded carotid artery. There were also three
late TIAs (4.8%) and no late strokes involving the hemisphere supplied by the operative site. There were a total of 14 late
deaths. Fifteen patients had late >50% restenosis of the operative side. Six of these had neurologic events (TIA/stroke)
involving the hemisphere of the occluded carotid artery, in contrast to five of 48 patients with no restenosis who had
neurologic symptoms (P < .001). Freedom from late strokes in the hemisphere ipsilateral to the occluded carotid artery
at 1, 3, 5, and 10 years was 98%, 96%, 96%, and 96%, respectively. The stroke-free survival rates at 1, 3, 5, and 10 years
were 90%, 87%, 80%, and 59%, respectively.
Conclusions: The natural history of carotid artery occlusion contralateral to CEA is relatively benign. This may suggest a
protective effect of carotid endarterectomy on the cerebral hemisphere ipsilateral to the carotid occlusion from late
strokes. ( J Vasc Surg 2006;44:62-6.)The natural history of patients with carotid artery oc-
clusion is controversial. It is generally thought that internal
carotid artery (ICA) occlusion initially correlates with po-
tentially serious neurologic events; however, once the oc-
clusion is established, the incidence of subsequent neuro-
logic events seems to be lower.1-6 Nicholls et al4 concluded
that when ICA occlusion occurs, patients have an initial risk
of ipsilateral stroke that can be as high as 25%. The subse-
quent risk of stroke ipsilateral to the occlusion appears to
vary according to its initial clinical presentation, with the
incidence of stroke reported to range from 0% to 5%
annually in patients with asymptomatic occlusions6,7 to as
high as 27% in patients with symptomatic occlusions.1,2
Few previously reported studies have analyzed the nat-
ural history of ICA occlusion contralateral to carotid end-
arterectomy (CEA).8-10 This study analyzes the natural
history of patients with carotid artery occlusion contralat-
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62eral to CEA, specifically assessing long-term neurologic
events occurring in the hemisphere associated with the
occluded carotid artery.
METHODS
Of 599 CEAs in 544 patients that were included in two
previous prospective trials, 63 patients had contralateral
ICA occlusion.11,12 This study will only analyze the natural
history of those patients with contralateral carotid artery
occlusion. The Institutional Review Board of our institu-
tion approved the study. Details of the two prospective
trials were described previously.11,12
Before surgery, all patients underwent carotid color du-
plex ultrasound scanning or magnetic resonance angiography
(MRA), or both, to determine preoperative stenosis. Various
preoperative risk factors were determined, including hyper-
tension, diabetes mellitus, smoking, coronary artery disease,
and the preoperative use of antiplatelet therapy.
All CEAs were done under general anesthesia, and
routine shunting was used. All patients were administered
aspirin therapy (325 mg daily) 24 hours after the opera-
tion or Plavix (75 mg daily) (Bristol-Myers Squibb, New
York, NY) if aspirin was contraindicated. Eighty-three per-
cent of these patients had preoperative antiplatelet therapy.
The diagnosis of ICA occlusion was accomplished by
duplex ultrasound imaging with or without MRA. Ultra-
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flow in the ICA, detection of a diastolic flow towards zero
in the common carotid artery, and a clear demonstration of
an external carotid artery and its collaterals. In patients with
suboptimal duplex imaging, MRA was done to confirm
carotid artery occlusion.
Postoperative surveillance protocol. All patients had
clinical and neurologic examinations postoperatively and
underwent immediate postoperative color duplex ultra-
sound scanning of the operated side, which was repeated at
30 days, 6 months, and every 6 months thereafter using an
ATL/HDI system 3000 and 5000 (Advanced Technology
Laboratory, Inc., Seattle, Was). Reportable complications
were determined in accordance with the Society of Vascular
Surgery Ad Hoc Committee Suggested Standards for Re-
ports Dealing with Cerebrovascular Disease.13 All patients
with early and late postoperative neurologic events were
examined clinically (including neurologic consultations)
and had computed tomography scanning or magnetic res-
onance imaging of the brain. They also had a carotid duplex
ultrasound and cardiac evaluation if the source of emboli
was not clear.
Statistical analysis. Kaplan-Meier life-table analysis
was used to calculate freedom from late strokes in the
hemisphere ipsilateral to the carotid occlusion. The stroke-
free survival rates were also calculated. Discrete variables
were compared using Fisher’s exact test.
RESULTS
As noted, 63 patients were in this study. The follow-up
was 58 months (range, 1 to 147 months). Table I summa-
rizes the demographic and clinical characteristics of this
series. The patients’ initial presentations included 14 (22%)
with hemispheric transient ischemic attacks (TIAs), 15
(24%) with hemispheric strokes, 5 (8%) with amaurosis
fugax, 14 (22%) with nonhemispheric TIAs, and 15 (24%)
Table I. Demographic and clinical characteristics
Characteristic Number (%)*
Sex
Male 44 (70)
Female 19 (30)
Age, mean (range) 66.54 (41–88)
Hypertension 46 (73)
Diabetes mellitus 18 (29)
Hyperlipidemia 33 (52)
Smoking 43 (68)
Coronary artery disease 31 (49)
Indications for surgery
Hemispheric TIA 14 (22)
Hemispheric stroke 15 (24)
Amaurosis fugax 5 (8)
Nonhemispheric
TIA
14 (22)
Asymptomatic 15 (24)
TIA, Transient ischemic attack.
*All data are number (%) except for age, which is mean (range).were asymptomatic. The perioperative complications aresummarized in Table II. As noted, one stroke (1.6%) oc-
curred on the operative side, and no strokes were ipsilateral
to the carotid occlusion.
The late neurologic events (TIAs and strokes) and
deaths are summarized in Table III. Two late strokes
(3.2%) occurred in the hemisphere ipsilateral to the oc-
cluded artery, one of which was similar to one that occurred
2 years before the CEA. The other patient had a prior
asymptomatic carotid occlusion. One of these patients had
a complete neurologic recovery. Nine late TIAs (14.3%)
occurred in the hemisphere ipsilateral to the carotid occlu-
sion. Five of these were similar to previous TIAs, and four
others were new transient ischemic events. All of these
patients were treated with antiplatelet therapy, except for
two patients who were treated with anticoagulation therapy
because of cardiac arrhythmias. There were also three
(4.8%) late TIAs but no late strokes involving the operative
side.
Of the two patients with strokes in the hemisphere
ipsilateral to the occluded carotid, one was associated with
50% restenosis of the operated side, and the other patient
demonstrated no recurrent stenosis. Five of the nine TIAs
involving the hemisphere ipsilateral to the occluded carotid
Table II. Perioperative complications
Complication Number (%)
TIA (operative side) 1 (1.6)*
Stroke (operative side) 1 (1.6)†
Stroke (ipsilateral to carotid occlusion) 0
Myocardial infarction 1 (1.6)
Congestive heart failure 1 (1.6)
Death 1 (1.6)
TIA, Transient ischemic attack.
*This patient had carotid endarterectomy with Hemashield (Boston Scien-
tific, Natick, Mass) patching.
†This patient had carotid endarterectomy with primary closure.
Table III. Late neurologic events and death
Event Number (%)
TIA (operative side) 3 (4.8)*
TIA (ipsilateral to carotid occlusion) 9 (14.3)†
Stroke (ipsilateral to carotid occlusion) 2 (3.2)‡
Death 14 (22.2)
Myocardial infarction 6
Congestive heart failure 1
Respiratory failure 1
Renal failure 1
Sepsis 1
Suicide 1
Cancer 1
Unknown 2
TIA, Transient ischemic attack.
*Two patients had primary closure, and one patient had aHemashield patch.
†Three patients had primary closure and six patients had patching (four
Hemashield patches and two polytetrafluoroethylene).
‡One patient had primary closure and one had Hemashield patching.were associated with 50% restenosis at the CEA site, and
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CEA site. Overall, 15 patients in the group had late 50%
restenosis, 10 of which had primary closure (only three of
these were 70%). Six of these restenosis were associated
with neurologic events (TIA or stroke) in the hemisphere
ipsilateral to the occluded carotid, in contrast to five of 48
patients with no restenosis who had neurologic events (P
.001).
Table IV summarizes the life-table analysis of freedom
from late strokes in the hemisphere ipsilateral to the carotid
occlusion (Fig 1). The freedom from stroke at 1, 3, 5, and
10 years was 98.2%, 96.4%, 96.4%, and 96.4%, respectively.
A total of 14 late deaths were caused by six myocardial
infarctions, one each from congestive heart failure, respira-
tory failure, renal failure, sepsis, suicide, and malignancy,
and two from an unknown cause. The stroke-free survival
rates are summarized in Table V and Fig 2. The stroke-free
survival rate at 1, 3, 5, and 10 years was 90.3%, 86.9%,
80.2%, and 58.8%, respectively.
DISCUSSION
Occlusion of the ICA represents end-stage disease of
the involved vessel. This potentially stroke-inducing event
can be prevented by CEA. Roederer et al14 found that
individuals at high risk for progression to occlusion have
80% diameter reduction of the ICA. Once the carotid
artery is occluded, an annual stroke rate of 3% can be
anticipated, with two thirds of events involving the ipsilat-
eral territory.15 Outcome appears to depend on the initial
neurologic presentation. Patients presenting with carotid
occlusion and hemispheric infarction have a fourfold in-
crease in the incidence of having a second hemispheric
stroke compared with patients whose initial presentation is
a TIA.16 Additionally, the risk of subsequent stroke in
Table IV. Freedom from late strokes (ipsilateral to carotid
Time interval risk
(mos.)
No. at risk
at start No. failed No. withd
0-1 63 0 1
1-6 62 0 5
6-12 57 1 1
12-18 55 0 1
18-24 54 1 3
24-30 50 0 1
30-36 49 0 3
36-42 46 0 4
42-48 42 0 6
48-54 36 0 4
54-60 32 0 6
60-72 26 0 9
72-84 17 0 1
84-96 16 0 3
96-108 13 0 3
108-120 10 0 4
120-132 6 0 2
132-144 4 0 0
144-156 4 0 4
SE, Standard error.patients with asymptomatic occlusion approaches 11%, re-sulting in a stroke-free rate of 89% at 4 years compared with
67% for symptomatic occlusions.15 In contrast, only two
late strokes in the hemisphere ipsilateral to the carotid
occlusion were noted in our series, resulting in a 96%
stroke-free rate at 5 years.
Other authors have suggested that the natural history
of the patent ICA contralateral to carotid occlusion is
different than in individuals without carotid occlusion.
Brengman et al17 looked specifically at the rate of disease
progression in the patent ICA by duplex examination and
the eventual need for CEA in patients with contralateral
carotid occlusion. Disease progression and the need for
subsequent CEA was 85% at 8 years in their series, and they
recommended frequent follow-up for a longer duration in
this population because disease appeared to progress over a
Fig 1. Kaplan-Meier life-table analysis of freedom from late
strokes (ipsilateral to the carotid occlusion).
lusion)
Interval survival
Cumulative contralateral
stroke-free SE
100 100 0
100 100 0
98.23 98.23 1.75
100 98.23 1.75
98.1 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53
100 96.36 2.53occ
rawnshort duration.17
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tive stroke is increased during CEA when the contralateral
ICA is occluded.18 Before 1980, perioperative stroke rates
of 11% and 13% were reported by Anderson et al19 and
Chung.20 However, more recent work by Mackey et al21
has demonstrated respective stroke rates of 4.8% and 2.6%
in their patients with contralateral occlusion. Ballotta et al22
evaluated presumed high-risk octogenarians with and with-
out contralateral carotid occlusion who completed CEA,
comparing the outcomes with younger groups of similarly
matched patients. Outcome differences among age groups
did not exist with respect to age or to severity of contralat-
eral occlusive disease.22 This updated version of our expe-
Table V. Stroke-free survival
Time interval
(mos.)
No. at risk
at start No. failed No. withdra
0–1 63 1 0
1–6 62 3 2
6–12 57 2 0
12–18 55 0 1
18–24 54 2 2
24–30 50 0 1
30–36 49 0 3
36–42 46 0 4
42–48 42 2 4
48–54 36 1 3
54–60 32 0 6
60–72 26 1 8
72–84 17 0 1
84–96 16 2 1
96–108 13 0 3
108–120 10 1 3
120–132 6 1 1
132–144 4 0 0
144–156 4 0 4
SE, Standard error.
Fig 2. Kaplan-Meier life-table analysis of stroke-free survival
rates.rience with ICA occlusion indicates that CEA does notresult in an increased risk of perioperative strokes or TIAs,
irrespective of contralateral ICA patency.23
Is there then a protective effect for the cerebral hemi-
sphere ipsilateral to the carotid occlusion with contralateral
CEA? Mackey et al21 reported a 5-year cumulative stroke
rate of only 2% in patients with an occluded carotid after
contralateral CEA. Nicholls et al15 reported a 5-year cumu-
lative stroke rate of 11% in patients who had CEA, com-
pared with a 22% cumulative stroke rate for those who did
require CEA contralateral to the occlusion. Similarly, in our
series, only two late (3.2%) strokes occurred in the hemi-
sphere ipsilateral to the carotid occlusion, which may sug-
gest that contralateral CEA may provide a protective effect
for the hemisphere ipsilateral to the occlusion. In addition,
patients with recurrent stenosis after CEA were at an in-
creased risk of late neurologic events in the hemisphere
ipsilateral to the occluded artery. Indeed, neurologic events
(TIA/stroke) developed in 40% of patients with 50%
restenosis vs 10% in patients without recurrent disease after
CEA (P  .001).
Finally, 5-year survival among patients with carotid
occlusion has been reported at 63% to 77%.16,24 Stroke-free
survival in our series was similar, with a survival rate of 80%
at 5 years and 59% at 10 years. Cardiac-related events
accounted for 50% of deaths in our series. These findings
were comparable with previously published reports.4,15
CONCLUSION
Thus, based on review of our prospective database, we
conclude that CEA contralateral to a carotid occlusion can
be performed with acceptable perioperative morbidity and
mortality rates. Additionally, the natural history of carotid
artery occlusion contralateral to CEA appears more benign
than what was previously reported for similar patients not
Interval survival
Cumulative contralateral
stroke-free SE
98.41 98.41 1.57
95.08 93.57 3.11
96.49 90.29 3.77
100 90.29 3.77
96.23 86.88 4.33
100 86.88 4.33
100 86.88 4.33
100 86.88 4.33
95 82.54 5.09
97.1 80.15 5.47
100 80.15 5.47
95.45 76.50 6.32
100 76.50 6.32
87.1 66.63 8.53
100 66.63 8.53
88.24 58.79 10.53
81.82 48.10 12.95
100 48.10 12.95
100 48.10 12.95wnundergoing CEA. Likewise, patients with recurrent steno-
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events ipsilateral to the occluded artery than those free from
restenosis. This suggests an overall protective effect in the
hemisphere ipsilateral to the carotid occlusion from late
stroke when CEA is performed for occlusive disease of the
contralateral ICA.
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